RNA regulatory elements in the genomes of simple retroviruses

Seminars in Virology

Volumn 8, Issue 3, 1997, Pages 194-204

  Banks, Jennifer D ^a,b   Beemon, Karen L ^c   Linial, Maxine L ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Encapsidation; Retroviridae; RNA export; RNA packaging; RNA splicing

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RNA;

LIFE CYCLE; RETROVIRUS; REVIEW; VIRUS ASSEMBLY; VIRUS GENE; VIRUS GENOME;

RETROVIRIDAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0031419692     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0122     Document Type: Article

References (90)

1. Berkowitz R., Fisher J., Goff S. P. RNA packaging. Curr. top. Microbiol. Immunol. 214:1996;177-218.
2. Linial M. Creation of a processed pseudogene by retroviral infection. Cell. 49:1987;93-102.
3. Dornburg R., Temin H. M. Retroviral vector system for the study of cDNA gene formation. Mol. Cell. Biol. 8:1988;2328-2334.
4. Linial M., Medeiros E., Hayward W. S. An avian oncovirus mutant (SE. Cell. 15:1978;1371-1381.
5. Anderson D. J., Lee P., Levine K. L., Sang J., Shah S. A., Yang O. O., Shank P. R., Linial M. L. Molecular cloning and characterization of the RNA packaging-defective avian retrovirus SE21Q1b. J. Virol. 66:1992;204-216.
6. Kawai S., Koyama T. Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: Biological properties of mutant TK15 and mutant-induced transformants. J. Virol. 51:1984;147-153.
7. Koyama T., Harada F., Kawai S. Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: Biochemical properties of mutant TK15 and mutant-induced transformants. J. Virol. 51:1984;154-162.
8. Nishizawa M., Koyama T., Kawai S. Unusual features of the leader sequence of Rous sarcoma virus packaging mutant TK15. J. Virol. 55:1985;881-885.
9. Katz R. A., Terry R. W., Skalka A. M. A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 59:1986;163-167.
10. Stoker A. W., Bissell M. J. Development of avian sarcoma and leukosis virus-based vector-packaging cell lines. J. Virol. 62:1988;1008-1015.
11. Aronoff R., Hajjar A. M., Linial M. L. Avian retroviral RNA encapsidation: Reexamination of functional 5′ RNA sequences and the role of nucleocapsid cys-his motifs. J. Virol. 67:1993;178-188.
12. Yeo A., Banks J. D., Green K., Cepeda F., Linial M. L. J. Virol. 1998.
13. Jaeger J. A., Turner D. H., Zuker M. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA. 86:1989;7706-7710.
14. Jaeger J. A., Turner D. H., Zuker M. Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 183:1990;281-306.
15. Zuker M. On finding all suboptimal foldings of an RNA molecule. Science. 244:1989;48-52.
16. Knight J. B., Si Z. H., Stoltzfus C. M. A base-paired structure in the avian sarcoma virus 5′ leader is required for efficient encapsidation of RNA. J. Virol. 68:1994;4493-4502.
17. Z. Liu, J. D. Banks, M. L. Linial, 1997.
18. Mann R., Mulligan R. C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 153:1983;159.
19. Cepko C. L., Roberts B. E., Mulligan R. C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 37:1984;1053-1062.
20. Mann R., Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 54:1985;401-407.
21. Bender M. A., Palmer T. D., Gelinas R. E., Miller A. D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1987;1639-1646.
22. Adam M., Miller A. D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62:1988;3802-3806.
23. Murphy J., Goff S. P. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J. Virol. 63:1989;319-327.
24. Han L., Yun J. S., Wagner T. E. Inhibition of molony murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences. Proc. Natl. Acad. Sci. USA. 88:1991;4313-4317.
25. Alford R. L., Honda S., Lawrence C. B., Belmont J. W. RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology. 183:1991;611-619.
26. Konings D. A., Nash M. A., Maizel J. V., Arlinghaus R. B. Novel GACG-hairpin pair motif in the 5′ untranslated region of type C retroviruses related to murine leukemia virus. J. Virol. 66:1992;632-640.
27. Tsai W. P., Copeland T. D., Oroszlan S. Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural protein. Virology. 140:1985;289-312.
28. Watanabe S., Temin H. M. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of thegag. Proc. Natl. Acad. Sci. USA. 79:1982;5986-5990.
29. Embretson J. E., Temin H. M. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:1987;2675-2683.
30. Yang S., Temin H. M. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:1994;713-726.
31. Harrison G. P., Hunter E., Lever A. M. Secondary structure model of the Mason-Pfizer monkey virus 5′ leader sequence: identification of a structural motif common to a variety of retroviruses. J. Virol. 69:1995;2175-2186.
32. Katoh I., Kyushiki H., Sakamoto Y., Ikawa Y., Yoshinaka Y. Bovine leukemia virus matrix-associated protein MA(p15): Further processing and formation of a specific complex with the dimer of the 5′-terminal genomic RNA fragment. J. Virol. 65:1991;6845-6855.
33. Katoh I., Yasunaga T., Yoshinaka Y. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine and human retroviruses. J. Virol. 67:1993;1830-1839.
34. Mansky L. M., Krueger A. E., Temin H. M. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 69:1995;3282-3289.
35. Kurg A., Sommer G., Metspalu A. An RNA stem-loop structure involved in the packaging of bovine leukemia virus genomic RNA in vivo. Virology. 211:1995;434-442.
36. Aldovini A., Young R. A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging results in production of noninfectious virus. J. Virol. 64:1990;1920-1926.
37. Lever A., Gottlinger H., Haseltine W., Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:1989;4085-4087.
38. Buchschacher G. L., Panganiban A. T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66:1992;2731-2739.
39. Parolin C., Dorfman T., Palu G., Gottlinger H., Sodroski J. Analysis in human immunodeficiency virus type 1 ofcis. J. Virol. 68:1994;3888-3895.
40. Luban J., Goff S. P. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 68:1994;3784-3793.
41. Baudin F., Marquet R., Isel C., Darlix J. L., Ehresmann B., Ehresmann C. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229:1993;382-397.
42. Clever J., Sassetti C., Parslow T. G. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:1995;2101-2109.
43. Harrison G. P., Lever A. M. L. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66:1992;4144-4153.
44. McBride M. S., Panganiban A. T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:1996;2963-2973.
45. Rizvi T. A., Panganiban A. T. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:1993;2681-2688.
46. Hu J., Toft D. O., Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16:1997;59-68.
47. McNally M. T., Beemon K. Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66:1992;6-11.
48. Stoltzfus C. M., Lorenzen S. K., Berberich S. L. Noncoding region between the env and src genes of Rous sarcoma virus influences splicing efficiency at the src gene 3′ splice site. J. Virol. 61:1987;177-184.
49. Fu X-D, Katz R. A., Skalka A. M., Maniatis T. The role of branchpoint and 3′ exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:1991;211-220.
50. Katz R. A., Skalka A. M. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 10:1990;696-704.
51. Green M. R. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell Biol. 7:1991;559-599.
52. Katz R. A., Kotler M., Skalka A. M. cis. J. Virol. 62:1988;2686-2695.
53. Amendt B. A., Simpson S. B., Stoltzfus C. M. Inhibition of RNA splicing at the Rous sarcoma virus src 3′ splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J. Virol. 69:1995;5068-5076.
54. Berberich S. L., Stoltzfus C. M. Mutations in the regions of the Rous sarcoma virus 3′ splice sites: Implications for regulation of alternative splicing. J. Virol. 65:1991;2640-2646.
55. Arrigo S., Beemon K. Regulation of Rous sarcoma virus RNA splicing and stability. Mol. Cell. Biol. 8:1988;4858-4867.
56. Stoltzfus C. M., Fogarty S. J. Multiple regions in the Rous sarcoma virus src gene intron act incis. J. Virol. 63:1989;1669-1676.
57. McNally M. T., Gontarek R. R., Beemon K. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology. 185:1991;99-108.
58. Gontarek R. R., McNally M. T., Beemon K. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes Dev. 7:1993;1926-1936.
59. McNally L. M., McNally M. T. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J. Virol. 70:1996;1163-1172.
60. Smith M. R., Smith R. E., Dunkel I., Hou V., Beemon K. L., Hayward W. S. Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus. J. Virol. 1997.
61. Coffin J. M. Retroviridae: Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1767-1847.
62. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 338:1989;254-257.
63. Fischer U., Meyer S., Teufel M., Heckel C., Luhrmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:1994;4105-4112.
64. Cullen B. R. Regulation of HIV gene expression. AIDS. 9:1995;S19-S32.
65. Felber B. K., Pavlakis G. N. Molecular biology of HIV-1: Positive and negative regulatory elements important for virus expression. AIDS. 7:1993;S51-S62.
66. Dayton A. I. The Rev axis of HIV-1 and its associated host cofactors: A viral window onto the workings of eukaryotic posttranscriptional RNA processing. J. Biomed. Sci. 3:1996;69-77.
67. Felber B. K., Hadzopoulou-Cladaras M., Cladaras C., Copeland T., Pavlakis G. N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA. 86:1989;1495-1499.
68. Malim M. H., Cullen B. R. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:1993;6180-6189.
69. Feinberg M. B., Jarret R. F., Aldovini A., Gallo R. C., Wong-Staal F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 46:1986;807-817.
70. Felber B. K., Drysdale C. M., Pavlakis G. N. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64:1990;3734-3741.
71. Kjems J., Sharp P. A. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:1993;4769-4776.
72. Arrigo S. J., Chen I. S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:1991;808-819.
73. Cochrane A. W., Jones K. S., Beidas S., Dillon P. J., Skalka A. M., Rosen C. A. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:1991;5305-5313.
74. D'Agostino D. M., Felber B. K., Harrison J. E., Pavlakis G. N. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell. Biol. 12:1992;1375-1386.
75. Bray M., Prasad S., Dubay J. W., Hunter E., Jeang K. T., Rekosh D., Hammarskjold M. L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA. 91:1994;1256-1260.
76. Zolotukhin A. S., Valentin A., Pavlakis G. N., Felber B. K. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:1994;7944-7952.
77. Tabernero C., Zolotukhin A. S., Valentin A., Pavlakis G. N., Felber B. K. The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J. Virol. 70:1996;5998-6011.
78. Ernst R. K., Bray M., Rekosh D., Hammarskjold M. L. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:1997;135-144.
79. Ernst R. K., Bray M., Rekosh D., Hammarskjold M. L. Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element. RNA. 3:1997;210-222.
80. Tabernero C., Zolotukhin A. S., Bear J., Schneider R., Karsenty G., Felber B. K. Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J. Virol. 71:1997;95-101.
81. Ogert R. A., Lee L. H., Beemon K. L. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70:1996;3834-3843.
82. Coffin J. M. Structure, replication and recombination of retrovirus genomes. J. Gen. Virol. 42:1979;1-26.
83. Aronoff R., Linial M. L. Specificity of retroviral RNA packaging. J. Virol. 65:1991;71-80.
84. R. A. Ogert, C. S. Hibbert, S. A. Smith, J. G. Lieb II, K. L. Beemon, 1997.
85. Nasioulas G., Hughes S. H., Felber B. K., Whitcomb J. M. Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element. Proc. Natl. Acad. Sci. USA. 92:1995;11940-11944.
86. U. Fischer, R. A. Ogert, K. L. Beemon, 1997.
87. Battiste J. L., Mao H., Rao N. S., Tan R., Muhandiram D. R., Kay L. E., Frankel A. D., Williamson J. R. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex. Science. 273:1996;1547-1551.
88. Jain C., Belasco J. G. A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity rev variants isolated by a rapid genetic strategy. Cell. 87:1996;115-125.
89. Fischer U., Huber J., Boelens W. C., Mattaj I. W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
90. Sorge J., Ricci W., Hughes S. cis-acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J. Virol. 48:1983;667-675.